Montreal: A major clinical trial in Canada shows that an inexpensive anti-inflammatory drug called colchicine can significantly reduce the risk of complications and death from COVID-19, bringing "important hope" to sufferers, the lead researcher said Sunday.
from Google Alert - health https://ift.tt/3ociWdX
via IFTTT
0 comments:
Post a Comment